Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US
- PMID: 21107532
- DOI: 10.1007/s00198-010-1494-9
Prevalence and costs of osteoporotic patients with subsequent non-vertebral fractures in the US
Abstract
This study assesses prevalence of subsequent fractures during the year after incident osteoporosis-related non-vertebral fractures among privately insured and Medicare populations and compares costs between patients with and without subsequent fractures. Many non-vertebral fracture patients incur subsequent fractures, and those who do are significantly more costly during the year after incident fracture.
Introduction: To estimate the prevalence of subsequent osteoporosis-related non-vertebral (NV) fractures during the year following an incident NV fracture and compare costs between NV fracture patients with and without subsequent fractures.
Methods: Using insurance claims data (1999-2006), privately-insured (ages 18-64 years) and Medicare (ages 65+ years) patients with ≥1 subsequent osteoporosis-related NV fracture within a year of an incident osteoporosis-related NV fracture were matched to controls with incident NV fractures but no subsequent fractures. Subsequent fractures were identified as any claim for an NV fracture occurring >3 months after the incident NV fracture (>6 months were required for fractures occurring at the same site as the incident fracture). The study assessed prevalence of subsequent fractures and compared costs (from the payer's perspective) between patients with and without subsequent fractures over the year following an incident NV fracture.
Results: Among privately insured NV fracture patients, 14.1% had any subsequent NV fractures, 1.6% had subsequent hip fractures, and 13.0% had subsequent non-vertebral, non-hip (NVNH) fractures, while 22.6% of Medicare NV fracture patients had subsequent NV fractures, 9.4% had subsequent hip fractures, and 15.5% had subsequent NVNH fractures. Mean excess health care costs per privately insured subsequent fracture patient were $9,789 ($19,072 vs. $9,914, p < 0.01), while excess medical costs per Medicare subsequent fracture patient were $12,527 ($31,904 vs. $19,377, p < 0.01).
Conclusions: NV fracture patients are at substantial risk for subsequent NV fractures within 1 year, and patients who incur subsequent fractures are significantly more costly than those who do not during the year following an incident fracture.
Similar articles
-
Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.Pharmacoeconomics. 2010;28(5):395-409. doi: 10.2165/11531040-000000000-00000. Pharmacoeconomics. 2010. PMID: 20402541
-
Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US.Osteoporos Int. 2011 Jan;22(1):47-56. doi: 10.1007/s00198-010-1267-5. Epub 2010 May 20. Osteoporos Int. 2011. PMID: 20490782
-
Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture.J Manag Care Spec Pharm. 2017 Apr;23(4):461-471. doi: 10.18553/jmcp.2017.23.4.461. J Manag Care Spec Pharm. 2017. PMID: 28345441 Free PMC article.
-
Epidemiology and economic burden of osteoporosis in Switzerland.Arch Osteoporos. 2014;9:187. doi: 10.1007/s11657-014-0187-y. Epub 2014 Jun 27. Arch Osteoporos. 2014. PMID: 24970672 Review.
-
Other non-vertebral fractures.Best Pract Res Clin Rheumatol. 2013 Dec;27(6):731-41. doi: 10.1016/j.berh.2014.01.003. Best Pract Res Clin Rheumatol. 2013. PMID: 24836332 Review.
Cited by
-
The Relation Between Osteoporosis and Bone Fractures and Health-Related Quality of Life in Post-menopausal Saudi Women in the Jazan Region: A Cross-Sectional Study.Cureus. 2024 Feb 18;16(2):e54412. doi: 10.7759/cureus.54412. eCollection 2024 Feb. Cureus. 2024. PMID: 38505434 Free PMC article.
-
The imminent risk of a fracture-existing worldwide data: a systematic review and meta-analysis.Osteoporos Int. 2022 Dec;33(12):2453-2466. doi: 10.1007/s00198-022-06473-0. Epub 2022 Jul 1. Osteoporos Int. 2022. PMID: 35776148 Review.
-
Efficacy of the Combination of Teriparatide and Denosumab in the Treatment of Postmenopausal Osteoporosis: A Meta-Analysis.Front Pharmacol. 2022 May 24;13:888208. doi: 10.3389/fphar.2022.888208. eCollection 2022. Front Pharmacol. 2022. PMID: 35685637 Free PMC article.
-
The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis.Osteoporos Int. 2022 Sep;33(9):1871-1893. doi: 10.1007/s00198-022-06399-7. Epub 2022 Apr 15. Osteoporos Int. 2022. PMID: 35426508
-
Self-reported sleep characteristics and risk for incident vertebral and hip fracture in women.Sleep Health. 2022 Apr;8(2):234-241. doi: 10.1016/j.sleh.2021.11.011. Epub 2022 Feb 28. Sleep Health. 2022. PMID: 35241403 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
